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Integrin transmembrane (TM) and/or cytoplasmic domains
play a critical role in integrin bidirectional signaling. Although
it has been shown that TM and/or cytoplasmic  and  do-
mains associate in the resting state and separation of these do-
mains is required for both inside-out and outside-in signaling,
the role of TM homomeric association remains elusive. Forma-
tion of TM homo-oligomers was observed in micelles and bac-
terial membranes previously, and it has been proposed that
homomeric association is important for integrin activation
and clustering. This study addresses whether integrin TM do-
mains form homo-oligomers in mammalian cell membranes
using cysteine scanning mutagenesis. Our results show that
TM homomeric interaction does not occur before or after sol-
uble ligand binding or during inside-out activation. In addi-
tion, even though the cysteine mutants and the heterodimeric
disulfide-bounded mutant could form clusters after adhering
to immobilized ligand, the integrin TM domains do not form
homo-oligomers, suggesting that integrin TM homomeric as-
sociation is not critical for integrin clustering or outside-in
signaling. Therefore, integrin TM homo-oligomerization is not
required for integrin activation, ligand binding, or signaling.
Integrins are cell adhesion molecules that are essential for
many biological functions such as cell migration, survival, and
differentiation. These functions are accomplished by integrin
bidirectional signaling across the cell membrane. Inside-out
activation occurs when specific intracellular molecules such
as talin and kindlin bind to the integrin cytoplasmic domain,
leading to integrin conformational change and therefore high
affinity for extracellular ligands. Then, binding of multimeric
extracellular ligands results in outside-in signaling that is crit-
ical for many cellular processes. It has been shown that inte-
grin bidirectional signal transduction requires integrin struc-
tural change and lateral distribution (clustering) (1, 2).
Integrins are type I transmembrane (TM)2 proteins consist-
ing of two noncovalently associated  and  subunits, each
with a large extracellular domain, a single-span TM domain,
and a short cytoplasmic domain. Recent structural studies
have greatly advanced our understanding of integrin confor-
mational change during inside-out activation (3–9). Even
though relatively short, the integrin TM/cytoplasmic domains
play a crucial role in this process. It has been shown that the
association of  and  subunit TM/cytoplasmic domains is
critical for stabilizing integrins in the resting state (10–16).
When induced by binding of the  subunit cytoplasmic do-
main through talin or other intracellular molecules, the TM/
cytoplasmic domains separate (17, 18), driving integrin exten-
sion and shifting the ligand binding / headpiece to an open,
high affinity conformation (7, 19). Recently, the structure of
the TM/cytoplasmic domains in the resting state was pro-
posed based on Rosetta computational modeling and experi-
mental data using intact integrins on mammalian cell surface
(16). In this structure, the IIb GXXXGmotif and its counter-
parts in the 3 TM domains associate with ridge-in-groove
packing, and the IIb GFFKR motif and the 3 Lys716 in the
cytoplasmic segments play a critical role in / association.
The structures of complex and monomeric  and  subunit
TM/cytoplasmic domains have also been solved by NMR (8,
9, 20, 21). These studies have shed light on the structural basis
of integrin TM/cytoplasmic domain signaling across the
plasma membrane (22).
In contrast to the role of heterodimeric TM/cytoplasmic
domain association and dissociation, that of homo-oligomer-
ization of integrin TM domains in integrin signaling remains
elusive. In 2001, an NMR study of this region by Li et al. failed
to detect heterodimeric association between the  and  sub-
unit TM/cytoplasmic domains using TM/cytoplasmic frag-
ment peptides in micelles. Instead, they observed that the 
and  fragments tend to form homodimers and homotrimers,
respectively (23). Later, IIb and 3 TM helices were con-
firmed to form homo-oligomers in bacterial membranes using
the TOXCAT assay (24, 25). The  and  homomeric interac-
tions have been widely studied by computational modeling
(26–28). These studies showed that the homo-oligomeriza-
tion interface and the heterodimerization motifs largely over-
lap, but it seems that homomeric interaction is less specific
than the heterodimeric interaction (25). In 2003, asparagine
mutagenesis in the TM region of 3 subunit (with most ex-
periments on the mutation 3G708N) suggested that TM
homo-oligomerization contributes to integrin activation and
clustering (29). However, the mutation 3G708N, which was
reported to enhance trimerization in detergent and increase
ligand binding avidity in the transfected CHO cells (29), was
later found to activate the integrin by changing ligand binding
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affinity rather than valence (13). Furthermore, mutations that
disrupted homodimerization of integrin TM domains, which
also disrupted heterodimerization because the two interfaces
overlap, were shown to activate integrins for ligand binding,
suggesting that TM domain separation is sufficient to activate
integrins (14). Therefore, it was proposed that integrin TM
homo-oligomerization is not a critical step for inside-out acti-
vation, but instead, it may help to stabilize the integrin in the
high affinity state and be important for outside- in signaling
(24).
It has been shown that integrin outside-in signaling re-
quires both conformational change and clustering of inte-
grins. However, the mechanism of how integrins transmit
these signals across the plasma membrane through the TM/
cytoplasmic domains remains unknown. More specifically, it
is unclear whether integrin TM homo-oligomerization plays
any role in integrin clustering and signaling, even though it
has been proposed that it provides structural basis for this
process (29, 30). Importantly, although  and  TM homo-
oligomerization was found in micelles and bacterial cell mem-
branes (14,23,25,29,31), it has never been observed in mam-
malian cell membrane using full-length integrins. On the
contrary, the TM heterodimeric but not homomeric associa-
tion of integrin fragments was detected using mini-integrin
affinity capture method in mammalian cell membranes (32).
In this paper, we tested whether integrin TM domains form
homo-oligomers in mammalian cell membranes using disul-
fide scanning of intact integrin IIb3. Our results show that
integrin TM domains do not form homo-oligomers before or
after soluble ligand binding or during integrin inside-out and
outside-in signaling.
EXPERIMENTAL PROCEDURES
Plasmid Construction and Transient Transfection—Plas-
mids coding for full-length human IIb and 3 were sub-
cloned into pEF/V5-HisA and pcDNA3.1/Myc-His(), re-
spectively (33). Amino acid substitution in TM and TM
proximal regions to cysteine was made using site-directed
mutagenesis with the QuikChange kit (Stratagene). Con-
structs were transfected into 293T cells (American Type Cul-
ture Collection) using a FuGENE transfection kit (Roche Ap-
plied Science) according to the manufacturer’s instructions.
Immunoprecipitation—Twenty-four hours after transfec-
tion, 293T cells were treated with 20 g/ml 2-bromopalmi-
tate, metabolically labeled with [35S]cysteine/methionine for
1.5 h before adding chase medium containing 500 g/ml cys-
teine and 100 g/ml methionine, and cells were cultured for
17 h overnight (12). Then, cells were detached and suspended
in Tris-buffered saline (TBS) (106 cells in 100 l) supple-
mented with 5 mM Ca2, 1 mM Mn2 with 3 mg/ml fibrino-
gen or 1 mM Mn2 with 50 M RGD peptide and incubated at
room temperature for 30 min. Then, saponin was added to a
final concentration of 0.02%, and 20 M CuSO4/100 M o-
phenanthroline was added by 10-fold dilution from stock so-
lutions, and cells were incubated on ice for 10 min. Oxidation
was quenched by adding an equal volume of TBS containing
Ca2 and 5 mM N-ethylmaleimide. Cells were lysed by the
addition of an equal volume of 2% Triton X-100 and 0.1%
Nonidet P-40 in the same buffer for 10 min on ice. Cell lysate
was centrifuged and immunoprecipitated with 1 g of anti-3
mAb AP3 and protein G-Sepharose at 4 °C for 2 h. After three
washes with lysis buffer, precipitated integrin was dissolved
into 0.5% SDS sample buffer and subjected to nonreducing
7.5% SDS-PAGE and fluorography (12).
For IIbW967C mutant, 2 mM DTT was added to the 35S-
labeled cells and incubated at 37 °C for 10 min, washed twice
with TBS, and then oxidized by Cu-phenanthroline on ice for
10 min. Oxidation was quenched by adding an equal volume
of TBS containing Ca2 and 5 mM N-ethylmaleimide. Cells
were lysed, and integrins were immunoprecipitated as de-
scribed above.
To test whether integrins form TM homomeric disulfide
after adhering to the immobilized fibrinogen, 35S-labeled cells
were seeded on the surface of 6-well plates precoated with
immobilized fibrinogen and incubated at 37 °C for 1 h. After
washing twice with TBS, adherent cells were incubated on ice
with Cu-phenanthroline and saponin and quenched with 5
mM N-ethylmaleimide. Cells were lysed, and integrins were
immunoprecipitated as described above.
Ligand-induced Binding Site (LIBS) Epitope Expression—
LIBS epitope expression was measured as described (34). Briefly,
transfected cells suspended in HEPES-buffered saline supple-
mented with 5.5 mM glucose and 1% bovine serum albumin
(BSA) were incubated with either 5 mMCa2, 3 mg/ml fibrino-
gen, or 50 MGly-Arg-Gly-Asp-Ser-Pro peptide (GRGDSP) in
the presence of 1 mMMn2 at 37 °C for 15min, and then 10
g/ml anti-LIBS1 antibody was added. After incubation on ice
for 30min, cells were washed and stained with FITC-labeled
anti-mouse IgG on ice for 30min. The stained cells were sub-
jected to flow cytometry, and LIBS epitope expression was ex-
pressed as the percentage of mean fluorescence intensity of anti-
LIBS antibody relative to mean fluorescence intensity of the
conformation-independent anti-3mAbAP3.
Cell Spreading, Integrin Clustering, and Microscopy—Glass
bottom 6-well plates (MatTek Corporation, Ashland, MA)
were coated overnight at 4 °C with 20 g/ml human fibrino-
gen in phosphate-buffered saline (PBS) at pH 7.4 followed by
blocking with 1% BSA at room temperature for 1 h. The tran-
siently transfected HEK293T cells were detached by trypsin/
EDTA and washed three times with DMEM. Cells were
seeded on fibrinogen-coated dishes. After incubation at 37 °C
for 1 h, cells were washed 3 times with PBS and fixed with
3.7% formaldehyde in PBS at room temperature for 10 min or
for integrin clustering, 10 g/ml anti-3 mAb AP3 was added
at room temperature for 30 min followed by staining with 10
g/ml FITC-conjugated goat anti-mouse IgG for 30 min at
room temperature before fixation. 400 nM cytochalasin D was
added as control before seeding.
Differential interference contrast imaging was conducted
on a Leica TCS SP2 spectral confocal system, coupled to a
DM IRE2 inverted microscope with 63 oil objective. For the
quantification of cell spreading area, outlines of 100 randomly
selected adherent cells were generated, and the number of
pixels contained within each of these regions was measured
using ImageJ software (National Institutes of Health, Be-
thesda, MD).
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Cell Adhesion—Cell adhesion on immobilized human fi-
brinogen was assessed by the measurement of cellular lactate
dehydrogenase activity as described (1). Briefly, cells sus-
pended in HEPES-buffered saline supplemented with 5.5 mM
glucose, 1% bovine serum albumin, and 1 mm Ca2 were
added into flat bottom 12-well plates (1  105 cells/well) that
had been precoated with 20 g/ml fibrinogen and blocked
with 1% BSA. After incubation at 37 °C for 1 h, wells were
washed three times with HEPES-buffered saline supple-
mented as indicated above. Remaining adherent cells were
lysed with 1% Triton X-100, and lactate dehydrogenase activ-
ity was assayed using the Cytotoxicity Detection Kit (lactate
dehydrogenase) (Roche Applied Science) according to the
manufacturer’s instructions. Cell adhesion was expressed as a
percentage of bound cells relative to total input cells.
RESULTS
Integrin TM Domains Do Not Form Homo-oligomers before
or after Soluble Ligand Binding—Previously, cysteine mu-
tagenesis and heterodimeric disulfide scanning were used to
identify the integrin IIb and 3 TM interface in mammalian
cell membrane successfully (12, 16). Here, we used single-
cysteine mutations of the IIb and 3 TM region (IIb resi-
dues 965–995 and 3 residues 691–723; Fig. 1A) and applied
a similar method to determine whether the IIb or 3 TM
domains form homo-oligomers during integrin signaling. As
FIGURE 1. Integrin TM domains do not form homo-oligomers before and after soluble ligand binding. A, sequences of the IIb and 3 TM regions are
shown. Segments predicted as TM are boxed. Residues used for cysteine scanning in this study are indicated by heavy dots. B, lysates from 35S-labeled
HEK293T cell transfectants were immunoprecipitated with mAb AP3. Precipitates were subjected to nonreducing 7.5% SDS-PAGE and fluorography. Except for
IIbW967C, none of the cysteine mutants of the IIb TM regions formed homomeric disulfide bonds before or after soluble ligand binding. C, none of the cysteine
mutants of the 3 TM regions formed homomeric disulfide bonds before or after soluble ligand binding. D, exposure of the LIBS1 epitope. LIBS epitope exposure
was determined as the percentage of mean fluorescence intensity of anti-LIBS1 antibody relative to nonfunctional anti-3 mAb AP3. Error bars are S.D.
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suggested by the TOXCAT assay (24, 25) and predicted by
computer modeling (26–28), the IIb TM helix forms ho-
modimers, and the 3 TM helix forms homotrimers, using
surfaces that are similar to those in the heterodimeric inter-
face. If this homomeric interface is actually formed in the
mammalian cell membrane, we expected that some single-
cysteine mutations of these residues would form ho-
modimeric disulfide bonds in the presence of an oxidation
catalyst such as Cu-phenanthroline. In addition, 2-bromo-
palmitate was used to block cysteine palmitoylation, which
can inhibit disulfide formation; and saponin was used to in-
crease the permeability of Cu-phenanthroline and the effi-
ciency of disulfide bond formation as described previously
(16). To confirm the efficiency of disulfide bond formation in
the presence of Cu-phenanthroline, several cysteine pairs
(one from  and the other from ) at the TM or TM proximal
region, which have been shown to form heterodimeric disul-
fide bonds (12, 16), were used as controls.
As shown in Fig. 1, the cysteine pair 971C/697C formed
a heterodimeric disulfide bond in the presence of Cu-phenan-
throline (Fig. 1B), as described previously (12). By contrast,
none of the single-cysteine mutants of IIb TM regions
formed homomeric disulfide bonds under these conditions
except IIbW967C (Figs. 1B and 2). As reported previously
(12, 13), IIbW967C, when co-transfected with wild-type 3,
formed a homomeric disulfide bond in the resting state, and
therefore, the IIb3 integrin associated to form a disulfide-
bridged tetramer (IIbW967C/3)2. This residue is located
outward, away from the heterodimeric interface or predicted
homodimeric interface (12, 13). When DTT was added, the
disulfide bond was reduced. After DTT was removed and Cu-
phenanthroline was added to catalyze disulfide formation,
only a trace amount of homomeric disulfide was formed on
the cell surface (Fig. 2A). We further traced the disulfide bond
formation of IIbW967C mutant after 35S labeling by lysing
cells and immunoprecipitating the protein at different time
points (Fig. 2B). After 30 min of labeling, IIb precursor was
formed. Then after 1 h, mature IIb subunit was formed, and
a trace amount of disulfide-bonded IIb was observed. In
1.5 h, a significant amount of disulfide-bonded dimeric
IIbW967C was formed. This suggests that the homomeric
disulfide bond is formed during biosynthesis and post-transla-
tional modification. Because this disulfide bond of the IIb
mutant is formed during biosynthesis and in the resting state
in which heterodimeric TM association is not affected, we
excluded this mutant for the following studies. None of
the other 30 IIb cysteine mutants formed a homomeric di-
sulfide bond (Fig. 1B and supplemental Fig. 1), and neither did
any of the 34 3 cysteine mutants (Fig. 1C and supplemental
Fig. 2). These results suggest that the IIb and 3 TM helices
do not form homomeric associations when IIb3 is in the
resting state.
To determine whether the  and  TM domains form
homo-oligomers after soluble ligand binding, we used Mn2
to activate integrin IIb3 followed by binding of soluble fi-
brinogen and ligand-mimetic RGD peptide. It has been shown
that ligand binding induces integrin conformational changes
that expose the LIBS epitopes, which are located at the inter-
faces between the headpiece and tailpiece and between the 
leg and  leg so that they are buried in the bent conformation
but exposed in the extended conformation (35, 36). We used
anti-3 LIBS mAb LIBS1 (37) to determine the conforma-
tional states of the IIb3 in the presence of Mn2 with fi-
brinogen or RGD. The LIBS1 bound poorly to wild-type
IIb3 in Ca2 (Fig. 1D), suggesting that it is in the bent con-
formation. The binding significantly increased when fibrino-
gen with Mn2 or RGD with Mn2 was added (Fig. 1D), sug-
gesting that these ligands bound to integrins, and they
stabilized integrins in the more extended conformation. Di-
sulfide scanning was used to test whether  and  TM do-
mains form homomeric interface after integrin bound to solu-
ble fibrinogen and RGD peptide under the same condition
(Fig. 1, B and C, and supplemental Figs. 1 and 2), and no ho-
momeric disulfide formation was observed for any mutants
except the W967C as described above, suggesting that after
ligand binding, even though integrins are stabilized in the
more extended state and probably with two separating legs
and TM/cytoplasmic tails, homo-oligomerization does not
occur for TM/cytoplasmic tails in mammalian cell membrane.
Integrin TM Domains Do Not Form Homo-oligomers during
Inside-out Signaling—We designed experiments to test
whether the integrin TM region forms homo-oligomers dur-
ing inside-out activation. It is well known that the GFFKR
motif in the IIb cytoplasmic domain is crucial for maintain-
ing integrin in the resting state. When the two phenylalanines
of the GFFKR motif are mutated to alanines (GAAKR mu-
tant), integrins are activated to bind ligands with high affinity.
Thus, this GAAKR mutant can be used to mimic integrin in-
side-out activation (12). We confirmed that the mutant bound
fibrinogen constitutively; in addition, it bound LIBS1 much
better than the wild-type in the Ca2 condition (Fig. 1D), in-
dicating that the mutation shifts integrin toward more ex-
tended conformation, well mimicking inside-out signaling.
We made six single-cysteine mutants using this GAAKR con-
struct and co-transfected them with the wild-type 3 integrin.
None of the IIb integrin cysteine mutants formed a homo-
meric disulfide bond (Fig. 3). Similar results were obtained
when 34 3 single-cysteine mutants were co-transfected with
the IIb GAAKR mutant; none of these mutants formed a
homomeric disulfide bond (Fig. 3). These results strongly sug-
FIGURE 2. The homomeric disulfide bond of the IIbW967C was formed
during biosynthesis. A, formation of the homomeric disulfide bond after
DTT treatment. The 35S-labeled cells were treated with or without 2 mM
DTT at 37 °C for 10 min. After washing with TBS, DTT-treated cells were
incubated with or without Cu-Phenanthroline. B, tracing the formation
of disulfide bond of IIb W967C mutant after labeling. The cells were
lysed at different periods of time after 35S labeling, and integrin IIb3
was immunoprecipitated and subjected to 7.5% nonreducing SDS-PAGE.
The additional bands of the  and / are probably due to the precur-
sors of the IIb subunit.
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gest that during integrin inside-out activation across the
mammalian cell membrane, TM homomeric association does
not occur. Therefore, the TM homo-oligomerization does not
play any role in this process.
Integrin TM Domains Do Not Form Homo-oligomers after
Adhering to Immobilized Fibrinogen—After binding to immo-
bilized ligands, integrins on the mammalian cell surface will
transmit outside-in signals. We carried out a series of experi-
ments to address whether TM homomers form during this
process. We randomly chose two IIb and two 3 cysteine
mutants and used them for cell adhesion and cell spreading
assay. HEK293T cells transiently transfected with wild-type
and mutant IIb3 were seeded on fibrinogen-precoated dish
surfaces at 37 °C for 1 h. The amount of adherent cells was
assessed by quantifying the cellular lactate dehydrogenase
activity. All selected mutants could adhere to the immobilized
fibrinogen similarly to the wild-type receptor, whereas the
disulfide-bounded mutant (968C/693C) showed much less
adhesion, and DTT treatment which was used to disrupt the
disulfide bond was able to recover its adhesion to the similar
level to the wild-type with DTT (Fig. 4A). To test whether the
single-cysteine mutations could affect cell spreading,
HEK293T transient transfectants were coated on the immobi-
lized fibrinogen at 37 °C for 1 h, followed by fixation and mi-
croscopic analysis. Cells transfected with all single-cysteine
mutants demonstrated cell spreading to a level similar to
those transfected with the wild-type receptor. By contrast, the
disulfide-bounded mutant (968C/693C) showed no spread-
ing, and DTT treatment restored cell spreading (Fig. 4, B and
C). These results confirmed that dissociation of the TM het-
erodimers is required for integrin outside-in signaling as de-
scribed previously using CHO cell transfectants (1). We also
chose four cysteine mutants (G972C, G976C, L705C, and
L712C), which were proposed to be critical for the homo-
meric interactions (25, 31), and used them for the cell spread-
ing assay. Cells transfected with all mutants showed cell
spreading similar to those transfected with the wild-type inte-
grin (data not shown). Taken together, our results indicate
that the single-cysteine mutations in this region do not affect
the integrin adhesion to immobilized fibrinogen, nor do they
affect outside-in signaling.
It is widely believed that lateral association (i.e. “cluster-
ing”) of integrin heterodimers, which occurs as a consequence
of multivalent ligand binding (38, 39), plays a major role in
outside-in signaling (40–42) (for review, see Ref. 43). It was
also shown that ligand binding can directly lead to and stabi-
lize separation of integrin cytoplasmic domains (44), and this
integrin conformational change is critical for outside-in sig-
naling as well (1). However, it remains unclear whether the
integrin TM homomeric interaction after the TM helix sepa-
ration is critical for integrin clustering. To assess formation of
integrin clustering, HEK293T transfectants were allowed to
adhere to fibrinogen-coated substrates followed by fixation
and staining with fluorescent anti-IIb3 antibodies. Under
these conditions, wild-type integrins and all cysteine mutants
could be readily detected in clustered patterns (Fig. 5). Inter-
estingly, although the disulfide-bounded 968C/693C mu-
tant is defective for cell spreading, it formed similar cell clus-
ters as others, in contrast to the negative control in which the
actin filament disruptor cytochalasin D prevented integrin
clustering (Figs. 4 and 5).
We then further determined, under the same conditions,
whether integrin TM domains formed homo-oligomers in the
plasma membrane. HEK293T cells transfected with a variety
of IIb and 3 cysteine mutants were seeded on a fibrinogen
substrate at 37 °C for 1 h. After cells fully adhered and spread
on immobilized fibrinogen, Cu-phenanthroline was added to
catalyze disulfide bond formation. Four cysteine mutation
pairs, 968C/693C, 971C/697C, 972C/697C, and
955C/723C, were used as controls to confirm the efficiency
FIGURE 3. Integrin TM domains do not form homo-oligomers during
inside-out activation. Samples were processed as in Fig. 1 and subjected
to nonreducing 7.5% SDS-PAGE and fluorography. A, cysteine mutations of
the IIb GAAKR mutant were co-transfected with wild-type 3 integrin. No
homomeric disulfide bond was formed for any of the IIb cysteine mutants.
B, cysteine mutations of the 3 TM region were co-transfected with the IIb
GAAKR mutant. No homomeric disulfide bond was formed for any of the 3
cysteine mutants.
FIGURE 4. Cell adhesion and spreading of randomly selected TM cys-
teine mutants. A, adhesion of HEK293T transfectants in the presence of
1 mM Ca2 to surfaces coated with 20 g/ml fibrinogen. The amount of
bound cells was determined by measuring lactate dehydrogenase activ-
ity as described under “Experimental Procedures.” Data are representa-
tive of three independent experiments, each in triplicate. B, differential
interference contrast images of HEK293T transfectants after adhering to
immobilized fibrinogen at 37 °C. The images are representative of three
independent experiments. Scale bar, 10 m. C, quantification of the ar-
eas of adhering/spreading cells as described under “Experimental Proce-
dures.” Error bars are S.D. ***, p  0.001.
Integrin Transmembrane Domain Homo-oligomerization
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of oxidation. Under this condition, four cysteine pairs formed
disulfides efficiently. By contrast, none of the IIb or 3 TM
cysteine mutations formed a homomeric disulfide bond (Figs.
6 and supplemental Fig. 3). Because these integrins adhered to
the immobilized fibrinogen, clustered on the cell surface and
transmitted outside-in signaling leading to cell spreading, the
results suggest that homomeric association of the integrin
TM domains is not important for integrin functions. Similar
results were obtained when CHO cells were used (data not
shown), suggesting that integrin TM/cytoplasmic domains do
not form homomeric interaction during integrin outside-in
signaling in mammalian cells.
DISCUSSION
It has been shown that TM heterodimeric association stabi-
lizes integrins in the resting state; when integrins are activated
by intracellular signals, two TM/cytoplasmic tails separate,
leading to conformational change of the ligand binding extra-
cellular regions, resulting in high affinity for ligands (5, 8, 9,
12, 13, 16–18, 45). Therefore, equilibrium between the disso-
ciated monomers and associated heterodimers of the TM do-
mains is critical for integrin inside-out activation. Based on
the observation that integrin TM helices formed homo-olig-
omers using recombinant peptides in detergent (23, 29, 31),
the GALLEX assay in bacteria (45), the TOXCAT assay in
bacteria (24, 25), and the computational modeling (26–28),
TM homomeric association has been suggested to be impor-
tant for integrin activation (14, 29, 31). Mutagenesis studies
on the proposed TM homomeric interface residues showed
that these mutations could lead to integrin activation, sug-
gesting that heterodimer dissociation is sufficient to activate
integrins (14). Therefore, a push-pull model was proposed in
which after dissociation of the TM heterodimer, integrins are
stabilized by TM homomeric association (14).
Here, our experiments on mammalian cell transfectants
using full-length integrin IIb3 showed that the IIb and 3
TM domains do not form any homomeric association in the
resting state, nor do they form after soluble ligand binding.
The only mutant that formed a homomeric disulfide is
IIbW967C, as reported previously (12, 13). We found that
this homomeric disulfide was formed during biosynthesis and
in the integrin resting state, and dissociation of the TM het-
erodimer is not required for its formation. Therefore, we do
not think that the same homomeric association occurs during
integrin inside-out activation or outside-in signaling. We
found that except for this mutant, none of the other 30 IIb
and 34 3 cysteine mutants formed a homomeric disulfide
bond before or after binding to soluble ligands. In addition,
during integrin inside-out activation, the integrin TM do-
mains do not form any homomeric association that can be
detected by disulfide scanning. Integrins must be regulated to
be activated and deactivated quickly in mammalian cells, even
within seconds. It has been shown that detachment of inte-
grin from ligands in the trailing edge is critical for integrin
functions (46), and mutations that constitutively active inte-
grins result in malfunctions (47–50). Therefore, it is unlikely
that integrin TM domains form more stable homomeric asso-
ciation during inside-out signaling.
We further showed that TM homomers do not form upon
to binding to ligands on a substrate and subsequent integrin
clustering. Although integrin clustering is known to partici-
pate in integrin signaling pathways (40, 51–53), the exact
mechanisms of integrin clustering remain elusive. One mech-
anism proposes that the integrin TM homo-oligomerization
promotes integrin clustering (29). Studies have established
that extracellular ligand binding triggers integrin conforma-
tional changes that promote oligomer assembly through TM
fragments (54–56). In this study, we observed that after ad-
hering to immobilized fibrinogen integrins clustered on the
cell surface, but we did not detect any integrin TM homo-
meric interaction under this condition. Interestingly, the het-
erodimeric disulfide-bonded integrin formed clusters, sug-
gesting that even the dissociation of integrin / TM
domains is not required for integrin clustering. In addition, no
evidence has been shown that the integrin extracellular do-
mains form homomeric interaction, and therefore, it is un-
likely that they induce integrin clustering during signaling.
FIGURE 5. Integrin clustering of selected TM cysteine mutants. Confocal
microscopy studies of integrin clustering on the cell surface are shown.
Cells expressing IIb3 wild type and mutants were seeded on fibrino-
gen-coated surface for 1 h at 37 °C in the presence or absence of cy-
tochalasin D (Cyto D). Attached cells were then stained with anti-3 mAb
AP3 in the presence or absence of cytochalasin D for 30 min at room
temperature, followed by staining with FITC-conjugated goat anti-
mouse IgG for 30 min at room temperature. After fixation, cells were
subjected to confocal microscopy.
FIGURE 6. Integrin TM domains do not form homo-oligomers after cells
adhering to the immobilized fibrinogen. Samples were processed as in
Fig. 1 and subjected to nonreducing 7.5% SDS-PAGE and fluorography.
A, none of the IIb cysteine mutants formed a homomeric disulfide bond
after adhering to the immobilized fibrinogen. B, none of the 3 cysteine
mutants formed a homomeric disulfide bond after adhering to the immobi-
lized fibrinogen.
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Taken together, our study suggests that integrin clustering is
likely induced by bringing several integrins physically close
together by multimeric ligands, and the TM/cytoplasmic do-
main homomeric association is not required for this process.
Additional evidence is needed to define the mechanisms of
integrin clustering further.
Even though the TM separation is not required for integrin
clustering, it is critical for integrin outside-in signaling (1).
We showed that all cysteine mutants could adhere and spread
on the fibrinogen-coated surface, suggesting that they could
transmit signals into the cells after binding to immobilized
ligands. However, we did not observe any TM homomeric
disulfide formation in the same condition, indicating that the
TM homomeric association does not occur during integrin
outside-in signaling. Based on the previous FRET studies (44),
we assume that ligand-induced TM separation is likely cou-
pled to cytoplasmic domain separation, implying that -
cytoplasmic domain interactions somehow constrain or in-
hibit kinase activation (1, 13, 17, 44, 57). One possibility is
that separation of TM and cytoplasmic domains induced by
multimeric ligand binding is required for kinases or other in-
tracellular proteins to bind integrin cytoplasmic tails. On the
other hand, some studies have shown that certain tyrosine
kinases, such as Src, associate constitutively with integrin
IIb3 in platelets, and platelet adhesion to fibrinogen causes
a rapid increase in Src activation (58). Thus, another possibil-
ity is that the association of the integrin TM and cytoplasmic
domains somehow constrains the activity of integrin tail-
bound kinases, whereas dissociation of the TM and cytoplas-
mic domains releases these constraints. In either case, binding
of multimeric ligands brings integrins together and at the
same time, induces dissociation of the TM/cytoplasmic do-
mains, resulting in kinase autophosphorylation and activa-
tion. The current study strongly suggests that during this
process, the TM homomeric association does not play any
role in kinase activation.
In conclusion, our study shows that the integrin TM homo-
meric association does not occur in mammalian cell mem-
branes before or after soluble ligand binding, during inside-
out activation or outside-in signaling. Therefore,
conformational change induced by intracellular signals or
extracellular ligands, more specifically, separation of TM and
cytoplasmic domains, but not the homomeric association, is
critical for integrin bidirectional signaling.
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46. Sáchez-Madrid, F., and del Pozo, M. A. (1999) EMBO J. 18, 501–511
47. Semmrich, M., Smith, A., Feterowski, C., Beer, S., Engelhardt, B., Busch,
D. H., Bartsch, B., Laschinger, M., Hogg, N., Pfeffer, K., and Holzmann,
B. (2005) J. Exp. Med. 201, 1987–1998
48. Park, E. J., Mora, J. R., Carman, C. V., Chen, J., Sasaki, Y., Cheng, G., von
Andrian, U. H., and Shimaoka, M. (2007) J. Clin. Invest. 117, 2526–2538
49. Imai, Y., Park, E. J., Peer, D., Peixoto, A., Cheng, G., von Andrian, U. H.,
Carman, C. V., and Shimaoka, M. (2008) Blood 112, 5007–5015
50. Park, E. J., Peixoto, A., Imai, Y., Goodarzi, A., Cheng, G., Carman,
C. V., von Andrian, U. H., and Shimaoka, M. (2010) Blood 115,
1572–1581
51. Kornberg, L. J., Earp, H. S., Turner, C. E., Prockop, C., and Juliano, R. L.
(1991) Proc. Natl. Acad. Sci. U.S.A. 88, 8392–8396
52. Kornberg, L., Earp, H. S., Parsons, J. T., Schaller, M., and Juliano, R. L.
(1992) J. Biol. Chem. 267, 23439–23442
53. Whitlock, B. B., Gardai, S., Fadok, V., Bratton, D., and Henson, P. M.
(2000) J. Cell Biol. 151, 1305–1320
54. Hantgan, R. R., Paumi, C., Rocco, M., and Weisel, J. W. (1999) Biochem-
istry 38, 14461–14474
55. Hantgan, R. R., Lyles, D. S., Mallett, T. C., Rocco, M., Nagaswami, C.,
and Weisel, J. W. (2003) J. Biol. Chem. 278, 3417–3426
56. Hantgan, R. R., Gibbs, W., Stahle, M. C., Aster, R. H., and Peterson, J. A.
(2004) Biochim. Biophys. Acta 1700, 19–25
57. Ye, F., Hu, G., Taylor, D., Ratnikov, B., Bobkov, A. A., McLean, M. A.,
Sligar, S. G., Taylor, K. A., and Ginsberg, M. H. (2010) J. Cell Biol. 188,
157–173
58. Obergfell, A., Eto, K., Mocsai, A., Buensuceso, C., Moores, S. L., Brugge,
J. S., Lowell, C. A., and Shattil, S. J. (2002) J. Cell Biol. 157, 265–275
Integrin Transmembrane Domain Homo-oligomerization
JANUARY 21, 2011 • VOLUME 286 • NUMBER 3 JOURNAL OF BIOLOGICAL CHEMISTRY 1867
